The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 27, 2021
Merck announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously voted in favor of updates to pneumococcal vaccination ...
read more
Wednesday, October 20, 2021
FDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose. ZIMHI is administered using a single-dose,...
read more
Thursday, October 14, 2021
Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, ...
read more
Thursday, October 07, 2021
GE Healthcare announced that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood ...
read more
Thursday, October 07, 2021
Specialist development pharmaceutical company AMZELL B.V. and the FDA have reached an agreement on the protocol for the Phase 3 trial of its infantile...
read more
Thursday, September 30, 2021
The CDC Foundation is announcing the launch of its new Vaccine Resource Hub—an online platform that will provide access to hundreds of free and ...
read more
Thursday, September 23, 2021
AbbVie announced that it has submitted an application to the FDA seeking approval for risankizumab-rzaa (600 mg intravenous (IV) induction and 360 mg ...
read more
Thursday, September 16, 2021
Theravance Biopharma, Inc. announced strategic actions to focus on leveraging its expertise in developing and commercializing respiratory therapeutics...
read more
Wednesday, September 15, 2021
The Novo Nordisk Foundation and the Broad Institute of MIT and Harvard announced the launch of the Novo Nordisk Foundation Center for Genomic ...
read more
Wednesday, September 08, 2021
Sandoz, a Novartis division, announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar ...
read more
Friday, September 03, 2021
Impel NeuroPharma Inc., a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high ...
read more
Friday, September 03, 2021
The FDA has approved Invega Hafyera (paliperidone palmitate) extended-release injectable suspension to treat schizophrenia in certain adults. Invega ...
read more
Wednesday, September 01, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the FDA has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month ...
read more
SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL announced a new collaboration to develop an inhaled dry powder formulation of ...
read more
Catalent, Inc., the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and ...
read more